Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000007394 | SCV002301499 | likely pathogenic | Holoprosencephaly 4 | 2024-08-05 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 28 of the TGIF1 protein (p.Ser28Cys). This variant is present in population databases (rs121909066, gnomAD 0.006%). This missense change has been observed in individuals with holoprosencephaly (PMID: 10835638; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6979). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TGIF1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects TGIF1 function (PMID: 10835638, 16962354). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Mendelics | RCV002247257 | SCV002516089 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000007394 | SCV003819488 | uncertain significance | Holoprosencephaly 4 | 2021-09-28 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000007394 | SCV000027593 | pathogenic | Holoprosencephaly 4 | 2000-06-01 | no assertion criteria provided | literature only |